827 results on '"Thornalley, Paul J."'
Search Results
2. Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload
3. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo
4. Increased cellular protein modification by methylglyoxal activates endoplasmic reticulum-based sensors of the unfolded protein response
5. Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
6. Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
7. Dicarbonyl stress, protein glycation and the unfolded protein response
8. A low glycemic diet protects disease-prone Nrf2-deficient mice against age-related macular degeneration
9. Hexokinase-2 Glycolytic Overload in Diabetes and Ischemia–Reperfusion Injury
10. Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications
11. Validation of plasma protein glycation and oxidation biomarkers for the diagnosis of autism
12. Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology—Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy
13. Advanced glycation end products in the pathogenesis of chronic kidney disease
14. Involvement of a gut–retina axis in protection against dietary glycemia-induced age-related macular degeneration
15. Genetic Deletion of DNAJB3 Using CRISPR-Cas9, Produced Discordant Phenotypes
16. High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
17. Contributors
18. Dicarbonyl stress and the glyoxalase system
19. Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia
20. The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity
21. Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal
22. Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemiainduced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications.
23. Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease
24. In vitro modeling of GCK mutation-associated monogenic diabetes using human iPSC and gene-editing technologies
25. Thiamine in Diabetic Renal Disease: Dietary Insufficiency, Renal Washout, Antistress Gene Response, Therapeutic Supplements, Risk Predictor, and Link to Genetic Susceptibility
26. Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients
27. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
28. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry — A user's perspective
29. Glycation- and/or Polyol Pathway-Inducing Complications
30. Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
31. Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo
32. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis
33. Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
34. Dicarbonyl stress in clinical obesity
35. Mass spectrometric determination of early and advanced glycation in biology
36. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
37. An Introduction to the Special Issue “Protein Glycation in Food, Nutrition, Health and Disease”
38. Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus
39. Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity
40. Oxygen restriction as challenge test reveals early high-fat-diet-induced changes in glucose and lipid metabolism
41. Disturbance of B-vitamin status in people with type 2 diabetes in Indonesia—Link to renal status, glycemic control and vascular inflammation
42. Dietary and Synthetic Activators of the Antistress Gene Response in Treatment of Renal Disease
43. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo
44. Glyoxalase in ageing
45. Glyoxalase in diabetes, obesity and related disorders
46. Glyoxalase in tumourigenesis and multidrug resistance
47. Unraveling the Biological Roles of Reactive Oxygen Species
48. Identification of Novel Circulating miRNAs in Patients with Acute Ischemic Stroke
49. Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
50. Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis—Driver of Insulin Resistance and Development of Vascular Complications of Diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.